Efficacy of Diuretics in Kidney Disease
NCT04542304 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 17
Last updated 2025-06-05
Summary
This study will determine the efficacy of diuretics in patients with chronic kidney disease.
Conditions
Interventions
- DRUG
-
Metolazone
Participants receive a single dose of metolazone.
- DRUG
-
Participants receive a single dose of placebo to match metolazone.
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2023-06-15
- Completion
- 2023-06-15
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Association of Diuretics With Change in Extracellular Volume, Natriuretic Peptides, Symptoms, and Cardiovascular Outcomes in CKD
NCT04192110 ·Status: WITHDRAWN ·Phase: PHASE4
-
Mineralocorticoid Receptor Antagonists in End Stage Renal Disease
NCT01691053 ·Status: COMPLETED ·Phase: PHASE2
-
Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing
NCT03746002 ·Status: TERMINATED ·Phase: PHASE4
-
Early Aldosterone Blockade in Acute Heart Failure: An Exploratory Safety Study
NCT02299726 ·Status: WITHDRAWN ·Phase: PHASE2
-
Chlorthalidone in Chronic Kidney Disease
NCT02841280 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of Chlorthalidone Among Patients With Poorly Controlled Hypertension and CKD
NCT01750294 ·Status: COMPLETED ·Phase: PHASE4
-
Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function
NCT01100203 ·Status: TERMINATED ·Phase: PHASE3
-
Inhibition of Aldosterone in Patients With Chronic Renal Disease
NCT00430924 ·Status: COMPLETED ·Phase: PHASE4
-
Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease
NCT00865501 ·Status: COMPLETED ·Phase: PHASE3
-
Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?
NCT00553722 ·Status: UNKNOWN ·Phase: PHASE4
-
Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease
NCT03141905 ·Status: COMPLETED ·Phase: NA
-
Comparing Diuretic Strategies in Hospitalized Heart Failure
NCT03999216 ·Status: WITHDRAWN ·Phase: PHASE4
-
Extracellular Fluid in Resistant Hypertension
NCT00141596 ·Status: TERMINATED ·Phase: NA
-
Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance
NCT03574857 ·Status: TERMINATED ·Phase: PHASE4
-
EBMtrialcentral- Comparing Initial Diuretic Therapies Using a Collaborative Network
NCT01748123 ·Status: WITHDRAWN ·Phase: PHASE4
-
Comparison of Single and Combination Diuretics in Low-Renin Hypertension
NCT02351973 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)
NCT04968184 ·Status: TERMINATED ·Phase: PHASE3
-
Intra-Renal Therapy of Diuretic Unresponsive Acute Kidney Injury
NCT01073189 ·Status: WITHDRAWN ·Phase: PHASE4
-
Loop Diuretics in Chronic Kidney Disease
NCT00478543 ·Status: COMPLETED ·Phase: PHASE4
-
Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
NCT00291720 ·Status: COMPLETED ·Phase: PHASE2
-
Aldosterone Antagonism in Diastolic Heart Failure
NCT00108251 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Diuretics in Maintenance Hemodialysis Patients Undergoing Bioimpedance-guided Fluid Management
NCT04182854 ·Status: UNKNOWN ·Phase: NA
-
Renal Denervation for Resistant Hypertension
NCT01865240 ·Status: TERMINATED ·Phase: PHASE4
-
Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation
NCT05498181 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease
NCT04531397 ·Status: WITHDRAWN ·Phase: PHASE4